GNMLF
Price
$1.22
Change
-$0.21 (-14.69%)
Updated
Apr 28 closing price
Capitalization
867.64M
VEXTF
Price
$0.08
Change
-$0.01 (-11.11%)
Updated
Apr 28 closing price
Capitalization
16.31M
Ad is loading...

GNMLF vs VEXTF

Header iconGNMLF vs VEXTF Comparison
Open Charts GNMLF vs VEXTFBanner chart's image
Genomma Lab International SAB DE CV
Price$1.22
Change-$0.21 (-14.69%)
Volume$1.48K
Capitalization867.64M
Vext Science
Price$0.08
Change-$0.01 (-11.11%)
Volume$70.52K
Capitalization16.31M
GNMLF vs VEXTF Comparison Chart
Loading...
View a ticker or compare two or three
VS
GNMLF vs. VEXTF commentary
May 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNMLF is a Hold and VEXTF is a Hold.

Ad is loading...
COMPARISON
Comparison
May 01, 2025
Stock price -- (GNMLF: $1.22 vs. VEXTF: $0.08)
Brand notoriety: GNMLF and VEXTF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: GNMLF: 420% vs. VEXTF: 222%
Market capitalization -- GNMLF: $867.64M vs. VEXTF: $16.31M
GNMLF [@Pharmaceuticals: Other] is valued at $867.64M. VEXTF’s [@Pharmaceuticals: Other] market capitalization is $16.31M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNMLF’s FA Score shows that 1 FA rating(s) are green whileVEXTF’s FA Score has 1 green FA rating(s).

  • GNMLF’s FA Score: 1 green, 4 red.
  • VEXTF’s FA Score: 1 green, 4 red.
According to our system of comparison, GNMLF is a better buy in the long-term than VEXTF.

Price Growth

GNMLF (@Pharmaceuticals: Other) experienced а -14.93% price change this week, while VEXTF (@Pharmaceuticals: Other) price change was -16.80% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +5.12%. For the same industry, the average monthly price growth was +1.70%, and the average quarterly price growth was -8.14%.

Reported Earning Dates

GNMLF is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+5.12% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
GNMLF($868M) has a higher market cap than VEXTF($16.3M). GNMLF has higher P/E ratio than VEXTF: GNMLF (9.47) vs VEXTF (3.80). GNMLF YTD gains are higher at: -4.213 vs. VEXTF (-26.437). GNMLF has higher annual earnings (EBITDA): 3.16B vs. VEXTF (10.1M). GNMLF has more cash in the bank: 1.37B vs. VEXTF (3.45M). VEXTF has less debt than GNMLF: VEXTF (39.8M) vs GNMLF (6.27B). GNMLF has higher revenues than VEXTF: GNMLF (17B) vs VEXTF (33.7M).
GNMLFVEXTFGNMLF / VEXTF
Capitalization868M16.3M5,325%
EBITDA3.16B10.1M31,257%
Gain YTD-4.213-26.43716%
P/E Ratio9.473.80249%
Revenue17B33.7M50,445%
Total Cash1.37B3.45M39,756%
Total Debt6.27B39.8M15,761%
FUNDAMENTALS RATINGS
GNMLF vs VEXTF: Fundamental Ratings
GNMLF
VEXTF
OUTLOOK RATING
1..100
9074
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
47
Fair valued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
4492
PRICE GROWTH RATING
1..100
5694
P/E GROWTH RATING
1..100
4014
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GNMLF's Valuation (13) in the null industry is somewhat better than the same rating for VEXTF (47). This means that GNMLF’s stock grew somewhat faster than VEXTF’s over the last 12 months.

GNMLF's Profit vs Risk Rating (69) in the null industry is in the same range as VEXTF (100). This means that GNMLF’s stock grew similarly to VEXTF’s over the last 12 months.

GNMLF's SMR Rating (44) in the null industry is somewhat better than the same rating for VEXTF (92). This means that GNMLF’s stock grew somewhat faster than VEXTF’s over the last 12 months.

GNMLF's Price Growth Rating (56) in the null industry is somewhat better than the same rating for VEXTF (94). This means that GNMLF’s stock grew somewhat faster than VEXTF’s over the last 12 months.

VEXTF's P/E Growth Rating (14) in the null industry is in the same range as GNMLF (40). This means that VEXTF’s stock grew similarly to GNMLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AZNIX11.33N/A
N/A
Virtus Income & Growth Inst
MKSPX26.76N/A
N/A
BlackRock Advantage SMID Cap K
AFCGX17.84N/A
N/A
American Century Focused Intl Gr G
VIDMX9.41N/A
N/A
Virtus KAR Developing Markets I
WFIOX50.46N/A
N/A
Allspring Index Admin

GNMLF and

Correlation & Price change

A.I.dvisor tells us that GNMLF and AQST have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNMLF and AQST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNMLF
1D Price
Change %
GNMLF100%
N/A
AQST - GNMLF
21%
Poorly correlated
+0.18%
LVRLF - GNMLF
20%
Poorly correlated
+46.60%
VEXTF - GNMLF
20%
Poorly correlated
N/A

VEXTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VEXTF has been loosely correlated with TCNNF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VEXTF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VEXTF
1D Price
Change %
VEXTF100%
N/A
TCNNF - VEXTF
40%
Loosely correlated
+8.64%
CURLF - VEXTF
37%
Loosely correlated
+1.66%
GTBIF - VEXTF
37%
Loosely correlated
+5.81%
AYRWF - VEXTF
36%
Loosely correlated
+5.13%
GLASF - VEXTF
34%
Loosely correlated
+6.08%
More